LT3216B - Contrast agent - Google Patents

Contrast agent Download PDF

Info

Publication number
LT3216B
LT3216B LTIP391A LTIP391A LT3216B LT 3216 B LT3216 B LT 3216B LT IP391 A LTIP391 A LT IP391A LT IP391 A LTIP391 A LT IP391A LT 3216 B LT3216 B LT 3216B
Authority
LT
Lithuania
Prior art keywords
polymer
contrast agent
mmol
added
group
Prior art date
Application number
LTIP391A
Other languages
English (en)
Lithuanian (lt)
Inventor
Jo Klaveness
Keith Redford
Pal Rongved
Jan Solberg
Per Strande
Unni Nordby Wiggen
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of LTIP391A publication Critical patent/LTIP391A/xx
Publication of LT3216B publication Critical patent/LT3216B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
LTIP391A 1992-03-06 1993-03-05 Contrast agent LT3216B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204918A GB9204918D0 (en) 1992-03-06 1992-03-06 Chemical compounds

Publications (2)

Publication Number Publication Date
LTIP391A LTIP391A (en) 1994-09-25
LT3216B true LT3216B (en) 1995-04-25

Family

ID=10711636

Family Applications (2)

Application Number Title Priority Date Filing Date
LTIP391A LT3216B (en) 1992-03-06 1993-03-05 Contrast agent
LTIP388A LT3199B (en) 1992-03-06 1993-03-05 Biodegradable non-crosslinked polymers of low or zero-water-solubility

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTIP388A LT3199B (en) 1992-03-06 1993-03-05 Biodegradable non-crosslinked polymers of low or zero-water-solubility

Country Status (30)

Country Link
US (1) US5574097A (lv)
EP (1) EP0629214B1 (lv)
JP (1) JP3281381B2 (lv)
CN (1) CN1038940C (lv)
AT (1) ATE144540T1 (lv)
AU (1) AU670069B2 (lv)
BG (1) BG99070A (lv)
BR (1) BR9306043A (lv)
CA (1) CA2130671A1 (lv)
CZ (1) CZ281738B6 (lv)
DE (1) DE69305628T2 (lv)
DK (1) DK0629214T3 (lv)
ES (1) ES2093413T3 (lv)
FI (1) FI944078A7 (lv)
GB (1) GB9204918D0 (lv)
GR (1) GR3022075T3 (lv)
HU (1) HUT69070A (lv)
IL (1) IL104962A (lv)
LT (2) LT3216B (lv)
LV (1) LV10294B (lv)
MD (2) MD940199A (lv)
NO (1) NO303123B1 (lv)
NZ (1) NZ249547A (lv)
OA (1) OA10097A (lv)
PH (1) PH30746A (lv)
PL (1) PL174125B1 (lv)
RU (1) RU2114865C1 (lv)
SK (1) SK105694A3 (lv)
WO (1) WO1993018070A1 (lv)
ZA (2) ZA931599B (lv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
GB9318288D0 (en) * 1993-09-03 1993-10-20 Nycomed Imaging As Improvements in or relating to contrast agents
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
GB9417941D0 (en) * 1994-09-06 1994-10-26 Nycomed Imaging As Improvements in or relating to contrast agents
CA2164237A1 (en) * 1994-12-08 1996-06-09 Takeharu Tabuchi Acrylic monomer
TW503116B (en) * 1997-12-12 2002-09-21 Kimberly Clark Co Structure having balanced pH profile
US6309999B1 (en) * 1999-03-19 2001-10-30 Chandra P. Sharma Process for the preparation of an immunoadsorbent matrix
RU2175338C2 (ru) * 1999-05-05 2001-10-27 Дугуев Сергей Владимирович Способ получения органоминеральных пигментов
US6720445B2 (en) 2000-12-21 2004-04-13 Beacon Laboratories, Inc. Acetyloxymethyl esters and methods for using the same
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ATE540678T1 (de) 2001-06-11 2012-01-15 Xenoport Inc Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
EP2075014B9 (en) 2002-05-24 2012-02-01 Angiotech International Ag Compositions and methods for coating medical implants
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
US20030235610A1 (en) * 2002-06-21 2003-12-25 Piedmont Pharmaceuticals, Llc Liposomes containing biologically active compounds
CA2536192A1 (en) * 2003-11-20 2005-06-09 Angiotech International Ag Soft tissue implants and anti-scarring agents
CA2584338C (en) 2004-11-04 2013-08-06 Xenoport, Inc. Gabapentin prodrug sustained release oral dosage forms
AU2005100176A4 (en) * 2005-03-01 2005-04-07 Gym Tv Pty Ltd Garbage bin clip
JP2011505179A (ja) 2007-11-23 2011-02-24 テヒニーシェ ウニヴェルジテート ウィーン ポリビニルアルコールベースの生分解性、生体適合性、架橋ポリマーの調製用重合硬化性組成物
ES2485899T3 (es) * 2010-06-17 2014-08-14 Basf Se Polímeros con grupos laterales sacárido y su uso
RU2543895C2 (ru) * 2013-05-17 2015-03-10 Общество С Ограниченной Ответственностью "Научно-Производственный Центр "Амфион" Гидрогелевый материал на основе сшиваемого поливинилового спирта
JP7115914B2 (ja) 2017-06-23 2022-08-09 住友化学株式会社 レジスト組成物及びレジストパターンの製造方法
GB201810788D0 (en) * 2018-06-29 2018-08-15 Biocompatibles Uk Ltd Biodegradable polymer
RU2687231C1 (ru) * 2018-08-03 2019-05-08 Сергей Борисович Врублевский Способ получения пигментов
CN109928879A (zh) * 2019-03-05 2019-06-25 贵州大学 一种丙烯酸酯碳酸酯及其均聚物和共聚物材料
CN111892707B (zh) * 2020-06-18 2021-08-13 中山大学 一种阳离子聚酰胺材料及其制备方法和应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002365A1 (en) 1979-05-04 1980-11-13 Rasor Ass Inc Ultrasonic image enhancement
EP0130935A1 (fr) 1983-07-01 1985-01-09 Battelle Memorial Institute Polypeptide biodégradable et son utilisation pour le relargage progressif de médicaments
US4774958A (en) 1985-12-05 1988-10-04 Feinstein Steven B Ultrasonic imaging agent and method of preparation
EP0327490A1 (de) 1988-02-05 1989-08-09 Schering Aktiengesellschaft Ultraschallkontrastmittel, Verfahren zu deren Herstellung und deren Verwendung als Diagnostika und Therapeutika
WO1991012823A1 (en) 1990-02-20 1991-09-05 Delta Biotechnology Limited Diagnostic aid
EP0458745A1 (en) 1990-05-18 1991-11-27 BRACCO International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
EP0458079A2 (de) 1990-04-26 1991-11-27 Hoechst Aktiengesellschaft Ultraschall-Kontrastmittel, Verfahren zu ihrer Herstellung und Verwendung derselben als Diagnostika und Therapeutika
WO1992004392A1 (en) 1990-09-07 1992-03-19 Holmes, Michael, John Polymers containing diester units

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4741956A (en) * 1986-07-09 1988-05-03 Exxon Research And Engineering Company Biodegradable coatings of ionomer polymer

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002365A1 (en) 1979-05-04 1980-11-13 Rasor Ass Inc Ultrasonic image enhancement
EP0130935A1 (fr) 1983-07-01 1985-01-09 Battelle Memorial Institute Polypeptide biodégradable et son utilisation pour le relargage progressif de médicaments
US4774958A (en) 1985-12-05 1988-10-04 Feinstein Steven B Ultrasonic imaging agent and method of preparation
EP0327490A1 (de) 1988-02-05 1989-08-09 Schering Aktiengesellschaft Ultraschallkontrastmittel, Verfahren zu deren Herstellung und deren Verwendung als Diagnostika und Therapeutika
WO1991012823A1 (en) 1990-02-20 1991-09-05 Delta Biotechnology Limited Diagnostic aid
EP0458079A2 (de) 1990-04-26 1991-11-27 Hoechst Aktiengesellschaft Ultraschall-Kontrastmittel, Verfahren zu ihrer Herstellung und Verwendung derselben als Diagnostika und Therapeutika
EP0458745A1 (en) 1990-05-18 1991-11-27 BRACCO International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
WO1992004392A1 (en) 1990-09-07 1992-03-19 Holmes, Michael, John Polymers containing diester units

Also Published As

Publication number Publication date
AU670069B2 (en) 1996-07-04
GB9204918D0 (en) 1992-04-22
BG99070A (bg) 1995-08-28
LTIP391A (en) 1994-09-25
CZ281738B6 (cs) 1997-01-15
DK0629214T3 (da) 1996-11-18
OA10097A (en) 1996-12-18
CN1038940C (zh) 1998-07-01
GR3022075T3 (en) 1997-03-31
NO943273L (no) 1994-09-05
AU3642393A (en) 1993-10-05
ZA931594B (en) 1993-09-27
JPH07505177A (ja) 1995-06-08
JP3281381B2 (ja) 2002-05-13
RU94045151A (ru) 1996-09-27
EP0629214B1 (en) 1996-10-23
HU9402563D0 (en) 1994-11-28
BR9306043A (pt) 1997-11-18
RU2114865C1 (ru) 1998-07-10
PL174125B1 (pl) 1998-06-30
WO1993018070A1 (en) 1993-09-16
IL104962A (en) 1996-01-31
SK105694A3 (en) 1995-04-12
PH30746A (en) 1997-10-17
DE69305628D1 (de) 1996-11-28
ES2093413T3 (es) 1996-12-16
EP0629214A1 (en) 1994-12-21
ZA931599B (en) 1993-12-28
MD940199A (ro) 1996-01-31
FI944078A0 (fi) 1994-09-05
US5574097A (en) 1996-11-12
LT3199B (en) 1995-03-27
NO303123B1 (no) 1998-06-02
LTIP388A (en) 1994-09-25
DE69305628T2 (de) 1997-03-06
MD940206A (ro) 1996-01-31
FI944078L (fi) 1994-09-05
NO943273D0 (no) 1994-09-05
LV10294B (en) 1995-12-20
FI944078A7 (fi) 1994-09-05
CA2130671A1 (en) 1993-09-07
HUT69070A (en) 1995-08-28
CN1084524A (zh) 1994-03-30
ATE144540T1 (de) 1996-11-15
CZ215294A3 (en) 1995-08-16
IL104962A0 (en) 1993-07-08
NZ249547A (en) 1996-08-27
LV10294A (lv) 1994-10-20

Similar Documents

Publication Publication Date Title
US5795562A (en) Contrast agents comprising gas-containing or gas-generating microparticles or microballoons
LT3216B (en) Contrast agent
US5674468A (en) Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons
JP3552721B2 (ja) ポリマー界面活性剤でカプセル封入された微小気泡および超音波画像形成でのその使用
US5569449A (en) Gaseous microparticles as ultrasound contrast agents
JP2003503522A (ja) 分解性架橋剤およびこれを用いて形成される架橋網目構造ポリマー
HK1006946B (en) Improvements in or relating to contrast agents
AU701907B2 (en) Improvements in or relating to contrast agents
KR101127895B1 (ko) 기체 생성과 생성된 기체의 함유가 가능한 다공성 고분자 마이크로 또는 나노 입자, 이의 제조 방법 및 용도
AU665198C (en) Improvements in or relating to contrast agents

Legal Events

Date Code Title Description
TK9A Rectifications: patents

Free format text: NYCOMED IMAGING AS, NYCOVEIEN 2, P.O. BOX 4220 TORSHOV, N-0401 OSLO 4, NO, 19951130

MM9A Lapsed patents

Effective date: 20000305